A detailed history of Banque De Luxembourg S.A. transactions in Abbott Laboratories stock. As of the latest transaction made, Banque De Luxembourg S.A. holds 4,239 shares of ABT stock, worth $553,655. This represents 0.26% of its overall portfolio holdings.

Number of Shares
4,239
Holding current value
$553,655
% of portfolio
0.26%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$111.93 - $119.39 $474,471 - $506,094
4,239 New
4,239 $481 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Banque De Luxembourg S.A. Portfolio

Follow Banque De Luxembourg S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque De Luxembourg S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banque De Luxembourg S.A. with notifications on news.